shutterstock_393927661_marbury
marbury / Shutterstock.com
3 May 2019Big Pharma

NHS partners with drugmakers to eliminate hep C

The National Health Service (NHS), the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme (MSD) and AbbVie to help eliminate hepatitis C in England.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
29 November 2018   The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.
Big Pharma
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Big Pharma
8 August 2019   The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

More on this story

Biotechnology
29 November 2018   The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.
Big Pharma
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Big Pharma
8 August 2019   The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

More on this story

Biotechnology
29 November 2018   The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.
Big Pharma
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Big Pharma
8 August 2019   The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.